Overview
Ming Lou practices practicing medicine in Xuzhou, China.
Their clinical expertise encompasses Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Autonomic Neuropathy.
They are actively involved in clinical research, co-authoring 28 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ming Lou
Is Ming Lou a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Ming Lou is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ming Lou participate in research or clinical trials?
Yes. Ming Lou has published 28 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Ming Lou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Autonomic NeuropathyLou isExperienced. Learn about Autonomic Neuropathy.
- Lung AdenocarcinomaLou isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerLou isExperienced. Learn about Lung Cancer.
- Neuroendocrine TumorLou isExperienced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)